Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

publishing date : 2022 - 04 - 01    tags : Nasdaq    save search

FedNat Receives Nasdaq Notification of Non-Compliance With Listing Rule 5250(c)(1)
Published: 2022-04-01 (Crawled : 22:00) - globenewswire.com
FNHC | $0.2 twitter stocktwits trandingview |
Finance
| Email alert Add to watchlist

nasdaq
Assembly Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Published: 2022-04-01 (Crawled : 22:00) - globenewswire.com
ASMB | $13.64 2.33% 2.27% 11K twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

nasdaq grant granted
Oncternal Therapeutics Reports Granting of Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
Published: 2022-04-01 (Crawled : 22:00) - globenewswire.com
ONCT | $8.97 4.3% 4.12% 4.5K twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

nasdaq therapeutics granted grant
Aravive Announces Closing of $10 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Published: 2022-04-01 (Crawled : 21:00) - biospace.com/
ARAV | $0.0401 4.74% 4M twitter stocktwits trandingview |
Health Technology
| | O: 4.15% H: 0.0% C: -5.97%

offering nasdaq
Adicet Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2022-04-01 (Crawled : 21:00) - biospace.com/
ACET | $1.95 -3.7% -3.85% 730K twitter stocktwits trandingview |
Health Technology
| | O: 0.7% H: 4.43% C: 3.48%

nasdaq granted grant
Stagwell Inc. Reports Equity Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2022-04-01 (Crawled : 21:00) - prnewswire.com
STGW F | $5.58 0.72% 0.72% 480K twitter stocktwits trandingview |
| Email alert Add to watchlist

nasdaq granted grant
Surface Oncology Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
Published: 2022-04-01 (Crawled : 21:00) - globenewswire.com
SURF | $1.07 -0.93% -1.41% 0 twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

nasdaq grant granted
embecta completes spin-off from BD and lists on NASDAQ as a global leader in diabetes care
Published: 2022-04-01 (Crawled : 11:00) - globenewswire.com
BDX | $234.12 0.42% 0.0% 1.3M twitter stocktwits trandingview |
Health Technology
| | O: -3.49% H: 0.0% C: 0.0%

care nasdaq diabetes
Gainers vs Losers
67% 33%

Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M twitter stocktwits trandingview |
Finance

EGOX | $0.0515 43.06% 30.1% 330M twitter stocktwits trandingview |

OLB 4 | $0.33 -14.95% 25.53% 840K twitter stocktwits trandingview |
Technology Services

NVFY | $2.77 31.28% 23.83% 33M twitter stocktwits trandingview |
Consumer Durables

ZCMD | $1.87 28.97% 22.46% 31M twitter stocktwits trandingview |
Commercial Services

RCON | $0.1112 13.01% 21.28% 1.7M twitter stocktwits trandingview |
Distribution Services

WLGS | $0.59 18.0% 17.9% 2.3M twitter stocktwits trandingview |

UONE | $2.36 19.8% 16.53% 75K twitter stocktwits trandingview |
Consumer Services

RWOD | $9.54 19.3% 16.18% 6.1M twitter stocktwits trandingview |
n/a

BSFC | $0.0758 17.7% 15.04% 92M twitter stocktwits trandingview |
Manufacturing


Your saved searches
Save your searches and get alerts when important news are released.